March 15, 2018
Rose
A six-month pilot program conducted by Sharp Rees-Stealy Medical Group in San Diego found that diabetes patients using Glooko’s care management platform were more engaged with their care and achieved better control of their blood glucose levels, according to a case study released by the company.
from MobiHealthNews http://ift.tt/2FED0UO
March 15, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Valencell's partnership with earphone manufacturer leads to $10.5M raise- Digital brain biomarker startup raises $15M in Series B funding
- FDA approves wearable device for opioid withdrawal symptom treatment device
- Medical communication tool Medici rakes in $22.4M
- Studies lend credence to Click Therapeutics' digital therapeutic for depression
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment